Literature DB >> 6861268

Therapeutic effect of vincristine, adriamycin and prednisolone (VAP) in angioimmunoblastic lymphadenopathy (AIL).

A S Awidi, M S Tarawneh, M S Abu Khalaf, M S Al Khateeb, S S Amr.   

Abstract

Five patients, three males and two females, with angioimmunoblastic lymphadenopathy (AIL) are described. The two who received steroids had no response and died 2 and 6 months later. The three patients who received vincristine, adriamycin and prednisolone (VAP) went into remission early and are still in remission with a follow-up of 22-35 months. It is concluded that VAP is effective therapy in AIL.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861268     DOI: 10.1007/bf00255768

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  5 in total

1.  Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease.

Authors:  R J Lukes; B H Tindle
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

2.  Malignant lymphoma arising in angioimmunoblastic lymphadenopathy.

Authors:  B N Nathwani; H Rappaport; E M Moran; G A Pangalis; H Kim
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

3.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11-1980.

Authors: 
Journal:  N Engl J Med       Date:  1980-03-20       Impact factor: 91.245

4.  Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course.

Authors:  G Frizzera; E M Moran; H Rappaport
Journal:  Am J Med       Date:  1975-12       Impact factor: 4.965

5.  Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy.

Authors:  Y Kaneko; R A Larson; D Variakojis; J M Haren; J D Rowley
Journal:  Blood       Date:  1982-10       Impact factor: 22.113

  5 in total
  1 in total

1.  Cyclosporine, prednisone, and high-dose immunoglobulin treatment of angioimmunoblastic T-cell lymphoma refractory to prior CHOP or CHOP-like regimen.

Authors:  Xing-Gui Chen; He Huang; Ying Tian; Cheng-Cheng Guo; Chao-Yong Liang; Yao-Ling Gong; Ben-Yan Zou; Rui-Qing Cai; Tong-Yu Lin
Journal:  Chin J Cancer       Date:  2011-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.